CN101448551A - 查耳酮在治疗病毒性疾病中的应用 - Google Patents

查耳酮在治疗病毒性疾病中的应用 Download PDF

Info

Publication number
CN101448551A
CN101448551A CNA2006800257917A CN200680025791A CN101448551A CN 101448551 A CN101448551 A CN 101448551A CN A2006800257917 A CNA2006800257917 A CN A2006800257917A CN 200680025791 A CN200680025791 A CN 200680025791A CN 101448551 A CN101448551 A CN 101448551A
Authority
CN
China
Prior art keywords
hydrochloride
chalcone derivative
pharmaceutically acceptable
compositions
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800257917A
Other languages
English (en)
Chinese (zh)
Inventor
S·博杜帕利
K·马哈茂迪
C·萨里奥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Original Assignee
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Companies LLC
Publication of CN101448551A publication Critical patent/CN101448551A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2006800257917A 2005-05-24 2006-05-19 查耳酮在治疗病毒性疾病中的应用 Pending CN101448551A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/137,198 US20060270614A1 (en) 2005-05-24 2005-05-24 Use of chalcones for the treatment of viral disorders
US11/137,198 2005-05-24

Publications (1)

Publication Number Publication Date
CN101448551A true CN101448551A (zh) 2009-06-03

Family

ID=36942429

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800257917A Pending CN101448551A (zh) 2005-05-24 2006-05-19 查耳酮在治疗病毒性疾病中的应用

Country Status (8)

Country Link
US (1) US20060270614A1 (https=)
EP (1) EP1888174B1 (https=)
JP (1) JP5179352B2 (https=)
CN (1) CN101448551A (https=)
AU (1) AU2006251668B2 (https=)
BR (1) BRPI0610211A2 (https=)
CA (1) CA2609347C (https=)
WO (1) WO2006127539A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103755541A (zh) * 2014-02-19 2014-04-30 厦门大学 一类查尔酮衍生物及其制备方法和用途
CN106497891A (zh) * 2017-01-03 2017-03-15 郑州汉东科技有限公司 一种流感病毒疫苗的生产方法
KR101731159B1 (ko) 2015-02-04 2017-04-28 계명대학교 산학협력단 2',4'-디하이드록시칼콘 화합물을 유효성분으로 포함하는 항진균용 조성물
TWI896916B (zh) * 2022-12-02 2025-09-11 豐苗生物科技股份有限公司 柑橘屬萃取物、化合物、及其用於抑制新型冠狀病毒的用途

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221029A1 (en) * 2002-10-31 2008-09-11 Regents Of The University Of Colorado Methods for treatment of thiol-containing compound deficient conditions
EP4125981A4 (en) 2020-04-02 2023-12-27 Mollick, Peter J. THERAPEUTIC TREATMENT OF CORONAVIRUS DISEASE COVID-19
US20230338362A1 (en) * 2020-09-17 2023-10-26 Iaterion, Inc. Methods and compositions for treating viral infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279930A (en) * 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
CA1137082A (en) * 1979-05-23 1982-12-07 Isao Umeda Substituted acetophenones and process therefor
JP2913706B2 (ja) * 1988-11-21 1999-06-28 大日本インキ化学工業株式会社 カルコン誘導体及びその製造方法
EP0996432A2 (en) * 1997-06-26 2000-05-03 Statens Seruminstitut Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
US20030065039A1 (en) * 1997-06-26 2003-04-03 Statens Serum Institute Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
BR9908870A (pt) * 1998-03-16 2000-11-21 Procter & Gamble Processos para regularizarem a aparência da pele
AU735384B2 (en) * 1998-03-16 2001-07-05 Procter & Gamble Company, The Compositions for regulating skin appearance
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US20050069563A1 (en) * 2003-09-26 2005-03-31 Garner Michael D. Method for treating herpes simplex virus and fungal pimples with antifungal medication
CN1964627B (zh) * 2004-06-04 2011-10-19 华盛顿大学 治疗神经病变的方法和组合物
US20080166304A1 (en) * 2004-09-17 2008-07-10 The General Hospital Corpoartion Inactivation of Microorganisms With Multidrug Resistance Inhibitors and Phenothiaziniums

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103755541A (zh) * 2014-02-19 2014-04-30 厦门大学 一类查尔酮衍生物及其制备方法和用途
KR101731159B1 (ko) 2015-02-04 2017-04-28 계명대학교 산학협력단 2',4'-디하이드록시칼콘 화합물을 유효성분으로 포함하는 항진균용 조성물
CN106497891A (zh) * 2017-01-03 2017-03-15 郑州汉东科技有限公司 一种流感病毒疫苗的生产方法
CN106497891B (zh) * 2017-01-03 2019-11-08 上海青赛生物科技有限公司 一种流感病毒疫苗的生产方法
TWI896916B (zh) * 2022-12-02 2025-09-11 豐苗生物科技股份有限公司 柑橘屬萃取物、化合物、及其用於抑制新型冠狀病毒的用途

Also Published As

Publication number Publication date
BRPI0610211A2 (pt) 2010-11-09
EP1888174B1 (en) 2012-02-22
CA2609347C (en) 2013-12-31
WO2006127539A1 (en) 2006-11-30
EP1888174A1 (en) 2008-02-20
US20060270614A1 (en) 2006-11-30
CA2609347A1 (en) 2006-11-30
JP5179352B2 (ja) 2013-04-10
AU2006251668B2 (en) 2012-02-02
JP2008542275A (ja) 2008-11-27
AU2006251668A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
Zhang et al. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat
JP2009545607A (ja) ウイルス性疾患の治療のための抽出物の使用
AU2016202145B2 (en) Methods of Increasing Solubility of Poorly Soluble Compounds and Methods of Making and Using Formulations of Such Compounds
US9730953B2 (en) Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compound
US8029770B2 (en) Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer
US20020010128A1 (en) Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
US20050013853A1 (en) Anti-proliferative drugs
ES2532849T5 (es) Tratamiento con agonista de la melatonina
BRPI0714161A2 (pt) mÉtodos para melhorar o efeito adverso de envelhecimento em cÉlulas de mamÍferos, para tratar uma doenÇa de pele ou condiÇço da pele em um mamÍfero, para tratar uma condiÇço de inflamaÇço em um mamÍfero, e para melhorar o efeito adverso de envelhecimento sobre a pele humana
JPH05178764A (ja) 局所用あるいは経皮用製品におけるジブチルアジペートとイソプロピルミリステートの用途
JPH04505758A (ja) 即効で増強された解熱応答
CN101448551A (zh) 查耳酮在治疗病毒性疾病中的应用
US20150105349A1 (en) (R)-(-)-1,2-propanediol compositions and methods
SG192014A1 (en) (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
US10149858B2 (en) Treatment for migraine
WO2020230726A1 (ja) 大気汚染物質からの保護剤及び大気汚染物質からの保護用組成物
WO2018144841A1 (en) Topical voriconazole for the treatment of pain
SESSION XXXI ANNUAL CONFERENCE OF INDIAN PHARMACOLOGICAL SOCIETY DECEMBER 18-20, 1998, LUCKNOW

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090603